Abridge

Overview
Activities
News
Telehealth?
Hospital Management?
Product stageSegments
Go-to-Market
?
Technology Service Providers, GenAI-based Telehealth platforms
?

Abridge is a Pittsburgh-based startup that develops GenAI tools for medical documentation. The company's core product is an AI-powered platform that converts patient-clinician conversations into structured clinical notes in real time. The technology integrates seamlessly with electronic health record systems, allowing clinicians to review and verify the AI-generated notes before finalizing them. Abridge's solution aims to reduce the administrative burden on healthcare providers, potentially saving them 70 hours per month on documentation tasks. The platform supports over 14 languages and more than 50 medical specialties

The company's technology is built on a proprietary data set derived from over 1.5 million medical encounters, and it employs advanced natural language processing and machine learning techniques to ensure accuracy and efficiency in clinical documentation.

Key customers and partnerships

As of February 2024, the company’s solution was being used by around 5,000 clinicians.

In October 2024, Abridge partnered with OpenNotes, a health transparency research organization at BIDMC, to improve patient visit documentation. The partnership, part of BIDMC's new OpenNotes Lab initiative, would evaluate Abridge's AI-generated patient visit summaries through focus groups to enhance their usefulness and accessibility. 

Also in October 2024, the company partnered with Wolters Kluwer Health to integrate UpToDate, a clinical decision support solution, into its platform. Through the partnership, Abridge's AI-generated clinical notes would include links to relevant evidence-based recommendations from UpToDate, providing clinicians with immediate access to the latest clinical information at the point of care. 

In August 2024, Abridge partnered with Reid Health, a rural healthcare system, to implement AI-powered solutions across Reid's network. Through the partnership, Abridge's AI technology was integrated with Epic's workflow, automating clinical documentation in real-time. The partnership aimed to reduce clinicians' administrative burden, allowing Reid Health to focus more on patient care.

In July 2024, the company partnered with health IT giant Epic and healthcare system Mayo Clinic to create a GenAI documentation platform. The partnership aimed to integrate Abridge's AI transcription and documentation tools into Epic's EHR workflow for Mayo Clinic's nurses. The GenAI tool utilized Abridge's technology to automatically transcribe and summarize conversations between nurses and patients while leveraging Epic's expertise in EHR integration and Mayo Clinic's knowledge of nursing practices.

In June 2024, Abridge partnered with The University of Vermont Health Network to improve clinician well-being. Through the partnership, Abridge's AI-powered platform was deployed across the university’s health network to generate clinical notes from patient-clinician conversations in real-time. The company noted that the enterprise-wide rollout would initially cover primary care and later expand to specialties like cardiology and endocrinology.

In March 2024, Abridge partnered with not-for-profit health system Sutter Health, to implement Abridge’s AI platform for clinical documentation across Sutter's network in California.

HQ location:
500 Grant Street Suite 2900 Pittsburgh PA USA
Founded year:
2018
Employees:
101-250
IPO status:
Private
Total funding:
USD 207.5 mn
Last Funding:
USD 150.0 mn (Series C; Feb 2024)
Last valuation:
USD 850.0 mn (Feb 2024)
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.